This website uses cookies so that we can offer you the best possible user experience. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the website you find most interesting and useful.
Bluetongue
Vaccination is the most effective and practical measure to minimize losses associated with this disease
Affected species



Risk Factors
Increase of vector spread
- High temperature
- Lower rainfall and stagnant water
Subclinical reservoirs infected
Introduction of susceptible animals in endemic areas
TRANSMISSION
- Biological Vector
Infected midges can be moved wind-borne to distances between 2 and 300 Kms
- Transpacental transmission
By ingestion of unpasteurized milk or milk products.
SIGNS AND SYMPTOMS
- Hemorrhage & Edema
- Oral and Nasal lesions. Tissue ulceration, Salivation & Nasal discharge, Swelling of lips, tongue and jaw, Cyanosis of the tongue (Blue tongue)
- Pedal lesions. Coronary inflammation and lameness
- Temporary infertility and abortions
- Weight loss
ECONOMIC LOSSES
Livestock production
FRANCISCO JAVIER ORTEGO
Researcher at Centro de Investigación de Sanidad Animal (CISA-INIA)
Francisco Javier Ortego completed his doctoral thesis at Hospital Ramón y Cajal in Madrid under the supervision of Dr. Rafael Fernández Muñoz. He then pursued two postdoctoral studies for a total of 10 years, first at Yale University in the US and then at the Centro Nacional de Biotecnología-CSIC in Madrid, where he held a reinstatement contract from the Ministry of Education and Science and an I3P contract from the Ministry of Science and Technology. In February 2005, he joined the Centro de Investigación en Sanidad Animal (CISA-INIA/CSIC) as a Ramón y Cajal researcher and later became a Full Scientist of OPIs in 2008. Since then, he has been conducting research in the field of developing and optimizing universal vaccines against Arboviruses relevant to animal health, with a particular focus on the Bluetongue and African horse sickness viruses. This year, he is participating in three projects, two as a Co-IP, which aim to generate and evaluate vaccines against COVID-19. Additionally, he served as Deputy of ANEP from 2015-2017 and later as the coordinator of the Livestock and Aquaculture (GYA) sub-area of the AEI from 2017-2019.

BLUEVAC BTV RANGE
Our vaccines against the different serotypes of Bluetongue virus